ArticleApplied health economics and health policy2018

A Cost-Effectiveness Analysis of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) for Universal Mass Vaccination Implementation in New Zealand.

Lijoy Varghese et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.